Skip to main content
. 2017 Aug 17;12(8):e0183161. doi: 10.1371/journal.pone.0183161

Fig 4. EphrinB2 blockade by sEphB4-HSA in human eRMS xenograft models.

Fig 4

A, B. Kaplan-Meier curves for Rh18 (A) or PCB82 (B) xenograft models. n = 10–12 female mice per cohort per experiment. Black line, human serum albumin (HSA) control. Red line, soluble EphB4-HSA treatment. C, D. Western blots (C) showing Src phosphorylation from PCB82 human eRMS xenograft, lysates treated in vivo with either HSA or sEphB4-HSA were quantified for differences using densitometry (D). n = 10–11 female mcie per PCB82 cohort. p = 0.2539.